MINI WELL READY IOL is an innovative progressive intraocular lens for the surgical correction of presbyopia
Singapore, April 11th, 2018 - SIFI, Italian leader in the development of therapeutic solutions to treat ophthalmic disorders, is pleased to announce the approval of MINI WELL READY intraocular lens by Singapore’s HSA - Health Science's Authority. MINI WELL READY is an innovative, aspherical, EDOF, progressive IOL (intraocular lens) designed for the surgical correction of presbyopia.
Uncorrected presbyopia is one of the most important causes of visual impairment worldwide associated with the progressive aging of the population. It is an interference in vision due to a loss of lens accommodation that results in an inability to focus at near distances. It is the most common physiological change occurring in the adult eye. Main causes of presbyopia include progressive decrease in crystalline plasticity and reduced functional capacity in the ciliary muscle.
"It is today increasingly recognized that presbyopia is an aspect of refractive error that needs to be addressed." said Gilberto Dalesio, SIFI Chief Commercial Officer "Presbyopia affects quality of life so SIFI is again proud to bring such an innovative Intraocular Lens into the Asian Market".
Improvements brought on by MINI WELL READY intraocular lens are closely linked to the novel optical design that assures a continuum of focus between far vision and near vision, therefore positively affecting visual performances.
SIFI looks forward to offering such an innovation to Singapore and the entire Asia Pacific region in order to empower surgeons with such an advanced technology and better the quality of vision and life of presbyopia patients. In the coming months, IOL Mini WELL READY may be implanted in clinics and hospitals in Singapore that will include it in their services, offering patients a technologically advanced presbyopia solution in conjunction with cataract surgery. Furthermore, SIFI has also scheduled the registration of MINI WELL TORIC in Singapore, another breakthrough extended depth of focus intraocular lens, for a complete array of products designed for patients with presbyopia and astigmatism.
SIFI
SIFI is the leading Italian ophthalmic company, focused on eye care since 1935. SIFI designs, manufactures and markets innovative pharmaceutical specialty products, surgical and medical devices. Headquartered in Catania, Sicily, SIFI operates directly in Italy, Romania and Mexico with a staff of more than 370 people worldwide. Since June 2015, SIFI is backed by 21 Investimenti, a private equity firm founded by Alessandro Benetton, which supports the company’s international expansion and portfolio development strategy. More information available at www.sifigroup.com.
For information please contact Press & Communication SIFI SpA
c/o CITYnet - Rome
press@sifigroup.com
